Feature

Gene Test Guides Eczema Care

  • By

  • March 2, 2026

  • 3 min

Share

  • 1

    A 487-gene expression profile test was developed for atopic dermatitis.

  • 2

    The study identifies JAK inhibitor responders vs. Th2 biologic responders.

  • 3

    Noninvasive skin sampling was used for testing.

  • 4

    Higher clearance and symptom control were seen in JAK responders.

  • 5

    The assay aids in therapy selection tailored to molecular profiles.

  • 6

    Only patients aged 12+ were validated in the study.

  • 7

    Aim to enhance patient outcomes and streamline systemic therapy.

Original Source(s)

Related Content